CompoAtlas

FITOMEGA DRE 11 (Paziņots 2009.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000211/2009
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
MIC VOKS, SIA
Manufacturer
ALFA OMEGA S.R.L.
Form
Šķīdums
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
40-60 pilieni jeb 2-3ml dienā
Published pack size
50 ml pudele ar dozētāju
Published packaging
50 ml pudele ar dozētāju

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
Purva bērza mizas ekstraktsplants ; Purva bērza mizas ekstrakts ; Betula Pubescens ; 9 ; mgbetula pubescensPlant
Parastā virša ziedu ekstraktsplants ; Parastā virša ziedu ekstrakts ; Calluna vulgaris ; 9 ; mgcalluna vulgarisPlant
Parastā oša mizas un lapu ekstraktsplants ; Parastā oša mizas un lapu ekstrakts ; Fraxinus excelsior ; 9 ; mgfraxinus excelsiorPlant
Melleņu ogu ekstraktsplants ; Melleņu ogu ekstrakts ; Vaccinium myrtillus ; 9 ; mgvaccinium myrtillusPlant
Kaķa naga mizas ekstraktsplants ; Kaķa naga mizas ekstrakts ; Uncaria tomentosa ; 9 ; mguncaria tomentosaPlant
Dižskābarža ziedpumpuru ekstraktsplants ; Dižskābarža ziedpumpuru ekstrakts ; Fagus sylvatica ; 9 ; mgfagus sylvaticaPlant
SpirtsotherIngredients ; SpirtsNot recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Itālija

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Purva bērza mizas ekstrakts
    Read the warning, when it applies and the studies cited

    Birch

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney or cardiovascular disorders (Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 1998).

    Sources cited by Health Canada (4)
    • Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Health Canada monograph dated 28 August 2024

  • Melleņu ogu ekstrakts
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “FITOMEGA DRE 11 (Paziņots 2009.)”, https://compoatlas.com/en/supplements/latvia/2479-fitomega-dre-11-pazinots-2009, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line